These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 723966)

  • 1. The intestine as source of immunoreactive substance P in plasma of the cat.
    Gamse R; Mroz E; Leeman S; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):17-21. PubMed ID: 723966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography.
    Lembeck F; Bernatzky G; Gamse R; Saria A
    Peptides; 1985; 6 Suppl 3():231-6. PubMed ID: 2421261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue concentration and release of substance P-like immunoreactivity in the dental pulp.
    Brodin E; Gazelius B; Olgart L; Nilsson G
    Acta Physiol Scand; 1981 Feb; 111(2):141-9. PubMed ID: 6169251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin and distribution of capsaicin-sensitive substance P-immunoreactive nerves in the nasal mucosa.
    Lundblad L; Lundberg JM; Brodin E; Anggård A
    Acta Otolaryngol; 1983; 96(5-6):485-93. PubMed ID: 6195888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme immunoassay of a substance P-like immunoreactive substance in human plasma and saliva.
    Takeyama M; Mori K; Takayama F; Kondo K; Kitagawa K; Fujii N
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3494-6. PubMed ID: 1709394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P in human cord blood and its degradation by placenta in vitro.
    Skrabanek P; Balfe A; McDonald D; McKaigney J; Powell D
    Eur J Obstet Gynecol Reprod Biol; 1980 Dec; 11(3):157-61. PubMed ID: 6164582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the concentrations of substance P and neurotensin in the gastrointestinal tract of various mammals.
    Holzer P; Bucsics A; Saria A; Lembeck F
    Neuroscience; 1982; 7(11):2919-24. PubMed ID: 6185881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P is markedly increased in plasma of patients with hepatic coma.
    Hörtnagl H; Singer EA; Lenz K; Kleinberger G; Lochs H
    Lancet; 1984 Mar; 1(8375):480-3. PubMed ID: 6199630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does liver-intestine significantly degrade circulating endogenous substance P in man?
    Henriksen JH; Schaffalitzky de Muckadell OB; Bülow JB
    Scand J Gastroenterol; 1986 Apr; 21(3):300-4. PubMed ID: 2424079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P in the blood plasma in hypophysial portal vessels.
    Szkudlarek U; Cannon D; Corbally N; Traczyk WZ
    Acta Physiol Pol; 1986; 37(2):92-9. PubMed ID: 2431597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basal concentration of Substance P (SP) and Vasoactive Intestinal Peptide (VIP) in the blood serum of children with allergic dermatitis].
    Grzybowska-Chłebowczyk U; Woś H; Szymańska M; Kajor M
    Med Wieku Rozwoj; 2003; 7(1):43-8. PubMed ID: 13130168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P release in the spinal cord during the exercise pressor reflex in anaesthetized cats.
    Wilson LB; Fuchs IE; Matsukawa K; Mitchell JH; Wall PT
    J Physiol; 1993 Jan; 460():79-90. PubMed ID: 7683719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturalistic activation of barosensitive afferents release substance P in the nucleus tractus solitarius of the cat.
    Potts JT; Fuchs IE
    Brain Res; 2001 Mar; 893(1-2):155-64. PubMed ID: 11223003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P in the vagus nerve. Immunochemical and immunohistochemical evidence for axoplasmic transport.
    Gamse R; Lembeck F; Cuello AC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):37-44. PubMed ID: 85263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P and neurokinin A in the cat carotid body: localization, exogenous effects and changes in content in response to arterial pO2.
    Prabhakar NR; Landis SC; Kumar GK; Mullikin-Kilpatrick D; Cherniack NS; Leeman S
    Brain Res; 1989 Mar; 481(2):205-14. PubMed ID: 2470465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of substance P-like immunoreactivity in the cat dental pulp by antidromic nerve stimulation.
    Gazelius B; Brodin E; Olgart L
    Acta Physiol Scand; 1981 Mar; 111(3):319-27. PubMed ID: 6171998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminar localization of the sites of release of immunoreactive substance P in the dorsal horn with antibody-coated microelectrodes.
    Duggan AW; Hendry IA
    Neurosci Lett; 1986 Jul; 68(1):134-40. PubMed ID: 2425305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man.
    Lundberg JM; Hökfelt T; Martling CR; Saria A; Cuello C
    Cell Tissue Res; 1984; 235(2):251-61. PubMed ID: 6200231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY; Yaksh TL; Go VL
    Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of substance P- and methionine5-enkephalin-like immunoreactivity in nerve cells of the myenteric ganglia in the cat ileum.
    Domoto T; Gonda T; Oki M; Yanaihara N
    Neurosci Lett; 1984 Jun; 47(1):9-13. PubMed ID: 6205330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.